Brind.

New leadership within the FDA emphasized the importance of randomized controlled trials as of July 22, 2025.

1 report, 1 independent Updated Jul 22

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA Vinay Prasad

Keep exploring

The entities involved

FDA
- Indian products were subject to an FDA recall.10:25
- FDA and HHS jointly presented food safety reforms, reviewing ultraprocessed food definitions and calling for congressional action on the GRAS program.06:54
Vinay Prasad
US hematologist–oncologist

Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped

Jul 22BloombergFDA Rejects Replimune’s Skin Cancer Treatment, Shares Sink (Bloomberg) -- Replimune Group Inc. shares sank to their lowest point ever after US regulators rejected a skin cancer treatment from the bio